bluebird bio Blazes Trail for Lentiviral Vectors at Upcoming FDA Meeting
June 7, 2022Bayer Oncology Leaders Fueling Ambitious 2030 “Top 10” Target
June 7, 2022Powered by its blockbuster checkpoint inhibitor Keytruda, Merck is forecasting a potential of more than 80 new regulatory approvals in oncology through 2028.
